Revenue
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Niagen Bioscience, Inc. (NAGE)
Price$3.17Cached quote
Net income
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $129.4M | $99.6M | $83.6M | $72.0M | $67.4M | $59.3M | $46.3M | $31.6M | $21.2M | $21.7M | $17.9M | $15.3M | $10.2M | $11.6M | $8.1M | $7.6M |
| Gross profit | $83.2M | $61.6M | $50.8M | $42.8M | $41.5M | $35.3M | $25.8M | $16.1M | $10.5M | $10.4M | $7.5M | $5.3M | $3.1M | $2.3M | $2.5M | $2.9M |
| Gross margin | 64.28% | 61.84% | 60.76% | 59.40% | 61.51% | 59.53% | 55.67% | 50.88% | 49.42% | 47.96% | 42.13% | 34.78% | 30.84% | 19.60% | 30.47% | 38.92% |
| Research & development | $6.3M | $6.0M | $5.0M | $4.8M | $3.8M | $3.4M | $4.4M | $5.5M | $4.0M | $2.5M | $891,601 | $513,671 | $134,040 | $142,000 | $96,788 | — |
| Operating expenses | $66.9M | $53.9M | $56.4M | $61.4M | $68.6M | $55.1M | $57.1M | $49.2M | $26.9M | $13.3M | $9.6M | $10.6M | $7.5M | $13.9M | $10.3M | $5.0M |
| Operating income | $16.3M | $7.7M | −$5.6M | −$18.6M | −$27.1M | −$19.9M | −$31.3M | −$33.2M | −$16.4M | −$2.9M | −$2.1M | −$5.2M | −$4.4M | −$11.6M | −$7.9M | −$2.0M |
| Operating margin | 12.58% | 7.76% | −6.70% | −25.85% | −40.14% | −33.50% | −67.62% | −105.12% | −77.25% | −13.41% | −11.55% | −34.16% | −43.17% | −100.22% | −96.94% | −26.66% |
| EBITDA | $17.1M | $8.5M | −$4.6M | −$17.6M | −$26.0M | −$18.7M | −$30.3M | −$32.6M | −$15.9M | −$2.6M | −$1.8M | −$5.0M | −$4.1M | −$11.3M | −$7.5M | −$1.6M |
| EBITDA margin | 13.18% | 8.57% | −5.47% | −24.39% | −38.49% | −31.62% | −65.44% | −103.19% | −74.84% | −11.88% | −9.95% | −32.71% | −40.75% | −97.26% | −92.02% | −21.54% |
| Net income | $17.4M | $8.6M | −$4.9M | −$16.5M | −$27.1M | −$19.9M | −$32.1M | −$33.3M | −$11.4M | −$2.9M | −$2.8M | −$5.4M | −$4.4M | −$11.7M | −$7.9M | −$2.1M |
| Net profit margin | 13.43% | 8.58% | −5.91% | −22.96% | −40.22% | −33.62% | −69.45% | −105.57% | −53.67% | −13.52% | −15.49% | −35.19% | −43.50% | −100.45% | −97.32% | −27.12% |
| Basic EPSper basic share | $0.22 | $0.11 | -$0.07 | -$0.24 | -$0.40 | -$0.33 | -$0.56 | -$0.61 | -$0.26 | -$0.08 | -$0.08 | -$0.15 | -$0.12 | -$0.39 | -$0.36 | — |
| Diluted EPSper diluted share | $0.20 | $0.11 | -$0.07 | -$0.24 | -$0.40 | -$0.33 | -$0.56 | -$0.61 | -$0.26 | -$0.08 | -$0.08 | -$0.15 | -$0.12 | -$0.39 | -$0.36 | -$0.12 |
Owners
Reported shareholders
≈24.45%of listed shares
Winsave Resources Ltd / Champion River Ventures Ltd / Brilliant Dynasty Ltd / Chau Hoi Shuen Solina Holly / Skyinvest Associates Ltd / Elgar International Ltd / Radiant Treasure Ltd / Pioneer Step Holdings Ltd / Dvorak International Ltd19.29M shares · Aug 20, 2024
View holders
| Holder | % owned |
|---|---|
Winsave Resources Ltd / Champion River Ventures Ltd / Brilliant Dynasty Ltd / Chau Hoi Shuen Solina Holly / Skyinvest Associates Ltd / Elgar International Ltd / Radiant Treasure Ltd / Pioneer Step Holdings Ltd / Dvorak International Ltd | ≈24.45%19.29M shares |
BlackRock, Inc. | 5.30%4.18M shares |
SteelPeak Wealth, LLC | 4.44%3.5M shares |
Jaksch Frank L Jr | ≈2.94%2.32M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 2.72%2.15M shares |
Tieton Capital Management, LLC | 2.55%2.01M shares |
Fried Robert N | ≈2.11%1.67M shares |
Qube Research & Technologies Ltd | 2.06%1.63M shares |
GEODE CAPITAL MANAGEMENT, LLC | 1.87%1.48M shares |
UBS Group AG | 1.63%1.28M shares |
GOLDMAN SACHS GROUP INC | 1.60%1.26M shares |
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.48%1.17M shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 1.48%1.17M shares |
STATE STREET CORP | 1.37%1.08M shares |
RENAISSANCE TECHNOLOGIES LLC | 0.84%659.58K shares |
CITADEL ADVISORS LLC | 0.80%630.11K shares |
DIMENSIONAL FUND ADVISORS LP | 0.77%605.33K shares |
MORGAN STANLEY | 0.64%504.77K shares |
VICTORY CAPITAL MANAGEMENT INC | 0.60%473.37K shares |
AQR CAPITAL MANAGEMENT LLC | 0.60%472.06K shares |
Percentages use 78.91M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Nov 14, 2025Form 4 | Pamir OzanChief Financial Officer | BuyCommon Stock · indirect | 2.2K | $6.85 | $15.2K | 2.2K |
| Nov 14, 2025Form 4 | Pamir OzanChief Financial Officer | BuyCommon Stock | 4.5K | $6.81 | $30.4K | 7.4K |
| Mar 7, 2025Form 4 | Lopez Carlos LuisSVP, General Counsel | BuyCommon Stock | 273 | $7.86 | $2.1K | 2.3K |
| Dec 13, 2024Form 4 | Jaksch Frank L JrDirector | SellCommon Stock | 37.2K | $6.19 | $230.0K | 244.2K |
| Nov 22, 2024Form 4 | Pamir OzanChief Financial Officer | BuyCommon Stock | 2.9K | $7.36 | $21.4K | 2.9K |